Thought in the midst of all this banter I'd have a look back over past company predictions and see how accurate or inaccurate they were.
20/12/2012 Predicted: Q1-2 2011 for conducting EU trial - Correct even though delayed a bit by weather - results published 14/7/11 Q3-4 2011 for EU approval for sale - Woefully out on that one.
30/9/2011 Predicted: - Commercialisation announcement in November 2011. Actual announcement was 28/11/2011 so spot on with that. - Sales to start in Q2 2012. Obviously missed but unknown by how much - Full trial report in Oct 2011. Not quite - 11/11/2011 - FDA classification in Oct 2011. Missed by a day - 1/11/2011 - FDA trial recruitment Dec 2011. Well that didn't happen. Can't remember why or if there has been an announcement.
28/11/2011 Predicted: - Q1 2012 FDA trial start. As above - Q2 2012 Sales to start. As above
2/12/2011 Predicted: - Q2 2012 SAles. As above.
8/2/2012 Predicted: - Early June 2012 SAles. As above.
27/3/2012 - End of May CE Mark approval. Didn't happen. Linked to sales. - End of June 2012 SAles. As above.
Hope this is a balanced view. I'm sure I'll be corrected if not.
It does occur to me though that a timeframe of about 1 year from final trial to commercialisation to approval to sales seems to be pretty good work.
Yes, I know some are frustrated and if your financial future is riding on a speedy result then I feel for you. I certainly don't mean to disregard your anxiety.
Rev
TIS Price at posting:
47.0¢ Sentiment: Buy Disclosure: Held